Skip to content

Long-term Effects of Family WISH Program for Adolescents With Congenital Heart Disease

Long-term Effects of Family WISH Program for Adolescents With Congenital Heart Disease

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06719323
Enrollment
104
Registered
2024-12-05
Start date
2026-06-01
Completion date
2027-07-31
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Defects, Congenital

Brief summary

The goal of this clinical trial is to learn the long-term effects of Family Walking Instruction with Support by Heart (Family WISH) on frailty state, quality of life and family functioning among adolescents with congenital heart disease (CHD). Researchers will compare the 12-week Family WISH program, based on self-efficacy theory, to a comparison group receiving a family walking health education sheet to evaluate the long-term effectiveness of the Family WISH program. Participants will: * Walk with family members for 20-30 minutes daily, at least 5 times per week, totaling 150 minutes per week. * Keep a diary to record the frequency of their walks and any symptoms experienced. * Complete questionnaires at baseline, and at 6, 12, and 24 weeks.

Interventions

BEHAVIORALFamily Walking Instruction with Support by Heart (Family WISH) program

Researchers will compare the 12-week Family WISH program, based on self-efficacy theory, to a comparison group receiving a family walking health education sheet to evaluate the long-term effectiveness of the Family WISH program.

a family walking health education sheet received

Sponsors

Chi-Wen Chen
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Outcomes Assessor)

Masking description

To ensure assessor blinding, different personnel conducted the interventions and outcome assessments.

Eligibility

Sex/Gender
ALL
Age
12 Years to 18 Years
Healthy volunteers
No

Inclusion criteria

* being between 12 and 18 years old; * having received a diagnosis of CHD by a physician before age 2; * having received a diagnosis of CHD with New York Heart Association (NYHA) functional class I, II, or III; * having parents or guardians who were able to communicate in Mandarin, and being able to communicate in Mandarin themselves; * not having cognitive impairments, and; * voluntarily signing informed consent forms.

Exclusion criteria

* undergoing heart transplant surgery within the past year; * receiving cardiac catheterization intervention or open-heart surgery within the past 6 months; * having CHD with NYHA functional class IV; and * having other congenital diseases

Design outcomes

Primary

MeasureTime frameDescription
frailty stateat baseline, and at 6, 12, and 24 weeksself-reported questionnaire completed

Secondary

MeasureTime frameDescription
quality of life and family functioningat baseline, and at 6, 12, and 24 weeksself-reported questionnaires completed

Countries

Taiwan

Contacts

Primary ContactChi-Wen Chen, PhD
chiwenchen@nycu.edu.tw011-886-228267348

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026